CYTOMEGALOVIRUS INFECTIONS
Clinical trials for CYTOMEGALOVIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets dangerous virus in transplant patients
Disease control Recruiting nowThis study tests an experimental treatment for cytomegalovirus (CMV) infection in people who have had a stem cell transplant. The treatment uses special immune cells from the donor that are trained to attack CMV. The goal is to see if this approach is safe and can help clear the …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: EARLY_PHASE1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New approach could reduce harsh drug side effects for transplant patients fighting CMV
Disease control Recruiting nowThis study is testing whether a drug called letermovir can prevent cytomegalovirus (CMV) infections from coming back in high-risk kidney or kidney/pancreas transplant patients. Researchers want to see if switching to letermovir earlier than usual can reduce the time patients need…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Apr 15, 2026 16:16 UTC
-
New software could speed up CMV diagnosis in pregnant women
Diagnosis Recruiting nowThis study tests a software tool called MyCMV that helps doctors interpret blood test results for cytomegalovirus (CMV) infection during pregnancy. CMV is a common virus that can cause hearing loss and developmental problems in babies if the mother gets infected while pregnant. T…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated May 17, 2026 03:01 UTC
-
New hope for transplant patients: extended drug course may stop dangerous virus
Prevention Recruiting nowThis study tests whether taking letermovir for a longer time (up to 28 weeks) can prevent cytomegalovirus (CMV) infection in 330 high-risk Chinese adults who have received a stem cell transplant. CMV is a common and serious complication in these patients because their immune syst…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated May 11, 2026 20:39 UTC
-
Immune-Guided drug timing could cut CMV risk after transplant
Prevention Recruiting nowThis study tests a personalized approach to prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant. Instead of giving the prevention drug Letermovir for a fixed 100 days, doctors will use a blood test to check when the patient's own immune syst…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE4 • Sponsor: WeiShi • Aim: Prevention
Last updated May 08, 2026 12:03 UTC
-
Lung transplant study tracks hidden virus breakthroughs
Knowledge-focused Recruiting nowThis study follows 40 lung transplant patients whose donor had CMV but who themselves had never been exposed to the virus. Researchers want to see how often CMV breaks through while patients take the antiviral drug valganciclovir, and what side effects occur. The goal is to bette…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC